No­vo Nordisk sues unau­tho­rized semaglu­tide com­pounders, tem­pers ex­pec­ta­tions for We­govy's glob­al roll­out

No­vo Nordisk is strik­ing back against il­le­gal semaglu­tide com­pounders, fil­ing an ini­tial five law­suits and prepar­ing more in the com­ing days and weeks.

The first le­gal ac­tions are aimed at stop­ping the sale of com­pound­ed prod­ucts claim­ing to in­clude semaglu­tide, a No­vo Nordisk spokesper­son said in an email to End­points News. The next round of law­suits al­ready in the works will ad­di­tion­al­ly tack­le false ad­ver­tis­ing and trade­mark in­fringe­ment re­gard­ing its semaglu­tide brands We­govy, Ozem­pic and Ry­bel­sus.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER